Paul A. Godley
MD, PhD, MPP
Executive Associate Dean for Faculty Affairs; Professor, Hematology/Oncology
Cancer Prevention and Control
Urologic Oncology Program
Area of interest
Dr. Godley's clinical interest include Prostate Cancer, especially advanced disease , Testicular Cancer , Urothelial cancers, including bladder , Kidney Cancer , and Penile Cancer.
Dr. Godley is a clinically active medical oncologist and epidemiologist who conducts a wide spectrum of research in prostate cancer. In an NCI-funded study, he has studied nutritional risk factors for prostate cancer, examined utility of tissue measurements of fatty acid composition as objective markers of essential fatty acid consumption among cases and controls, and explored racial differences in these factors and markers. His initial emphasis was on omega-3 and omega-6 fatty acids. He is also conducting NCI-funded research on biomarkers of past consumption of fat-soluble vitamins. He is currently Principal Investigator of an ongoing American Cancer Society funded case-control study of prostate cancer screening which seeks to define the efficacy of PSA screening, and PI of a study using SEER and Medicare data to investigate racial differences in prostate cancer treatment outcomes.
At the University of North Carolina, Dr. Godley holds a variety of positions and administrative posts. He is an associate professor in the Division of Hematology/Oncology at the School of Medicine; is an adjunct associate professor in the Department of Epidemiology in the School of Medicine Public Health as well as in the Department of Biostatistics; and serves on numerous key committee, including chairing the School of Medicine Data and Safety Monitoring Board and sitting on the Admissions Committee. In 2001 Dr. Godley became Director of the Program on Ethnicity, Culture, and Health Outcomes (ECHO), a university initiative to advance understanding and elimination of racial health disparities through multidisciplinary research, education and training, and community partnerships. Godley is the co-chair of the Prostate Cancer Task Force of the North Carolina Advisory Committee on Cancer Coordination and Control and sits on the Prostate Committee of the CALGB (a national cancer clinical trials cooperative group). He is also Chairman of the Data and Safety Monitoring Committee for 2 large national prevention studies, the NCI-sponsored Prostate Cancer Prevention Trial and the NCI-sponsored SELECT prevention trial.
After graduating magna cum laude from Yale University, Dr. Godley concurrently earned his MD degree from Harvard Medical School and a Master of public policy degree from Harvard's John F. Kennedy School of Government. He completed his internship and residency at the Case Western Reserve University Hospitals, University Hospitals of Cleveland and the Cleveland VA Medical Center. He continued on to the University of North Carolina research fellowship in cancer epidemiology and a fellowship in hematology/oncology. While completing his fellowship training, Dr. Godley also earned a PhD degree in epidemiology at the university.
Awards and Honors
Dr. Godley is a recipient of the American Cancer Society Clinical Oncology Career Development Award and is a member of the American College of Physicians, American Society of Preventive Oncology, Society for the Epidemiologic Research, American Society of Clinical Oncology and American Society of Clinical Oncology and American Medical Association. In 2000 he took on the additional responsibility of an associate editorship for the Journal of the National Cancer Institute and sits on the ACS study section, "Clinical Research, Cancer Control and Epidemiology."
His most recently awarded grants are from the Agency for Health Care Research and Quality, where he is Co-PI of the program project grant, "Eliminating Racial Disparities in Health," and from the Centers for Disease Control where he is PI of a constituent case-case project comparing prostate cancer outcomes among African Americans and Caucasians.